Dosimetric quality assurance (QA) of the new Elekta Unity (MR-linac) will differ from the QA performed of a conventional linac due to the constant magnetic field, which creates an electron return effect (ERE). In this work we aim to validate PRESAGE(R) dosimetry in a transverse magnetic field, and assess its use to validate the research version of the Monaco TPS of the MR-linac. Cylindrical samples of PRESAGE(R) 3D dosimeter separated by an air gap were irradiated with a cobalt-60 unit, while placed between the poles of an electromagnet at 0.5 T and 1.5 T. This set-up was simulated in EGSnrc/Cavity Monte Carlo (MC) code and relative dose distributions were compared with measurements using 1D and 2D gamma criteria of 3% and 1.5mm. The irradiation conditions were adapted for the MR-linac and compared with Monaco TPS simulations. Measured and EGSnrc/Cavity simulated profiles showed good agreement with a gamma passing rate of 99.9% for 0.5T and 99.8% for 1.5T. Measurements on the MR-linac also compared well with Monaco TPS simulations, with a gamma passing rate of 98.4% at 1.5T. Results demonstrated that PRESAGE(R) can accurately measure dose and detect the ERE, encouraging its use as a QA tool to validate the Monaco TPS of the MR-linac for clinically relevant dose distributions at tissue-air boundaries.
In IOERT a single dose of radiation is delivered to the tumour site during surgery. Manual dose calculations are used and the irradiation target volume, electron energy and applicator are decided on site by the radiation oncologist. This work assesses the effect that irregular and curved surfaces, typical of pelvic IOERT, may have on the expected dose distribution. The feasibility of using Gafchromic EBT3 films and a slab phantom to obtain 2D dose distributions was investigated. Different set-ups were tested by comparison with water tank measurements, applying the gamma function analysis with 2% and 2 mm criteria. The validated set-up was then used to obtain reference dose distributions, which were converted to colour-coded graphical representations. Phantoms with step-like and curved surfaces were created to simulate typical pelvic IOERT irradiation surfaces, and the dose distributions were obtained and compared with the reference distributions. Good agreement with water tank measurements was obtained for all applicators below 2 mm, using the chosen setup in reference conditions. In non-reference conditions, the presence of a step-like surface creates an adjacent hotspot, followed by a quick reduction of the dose in depth. With curved surfaces, the dose distribution is shifted forward, becoming curved and deeper, but when the applicator is larger than the hole, hotspots are also observed. The shape of the irradiation surfaces alters the dose distribution. Visualization of these effects is important to assess target coverage and interpret in vivo measurements in pelvic IOERT.
Previous work has shown that PRESAGE® can be used successfully to perform 3D dosimetric measurements of complex radiotherapy treatments. However, measurements near the sample edges are known to be difficult to achieve. This is an issue when the doses at air-material interfaces are of interest, for example when investigating the electron return effect (ERE) present in treatments delivered by magnetic resonance (MR)-linac systems. To study this effect, a set of 3.5 cm-diameter cylindrical PRESAGE® samples was uniformly irradiated with multiple dose fractions, using either a conventional linac or an MR-linac. The samples were imaged between fractions using an optical-CT, to read out the corresponding accumulated doses. A calibration between TPS-predicted dose and optical-CT pixel value was determined for individual dosimeters as a function of radial distance from the axis of rotation. This data was used to develop a correction that was applied to four additional samples of PRESAGE® of the same formulation, irradiated with 3D-CRT and IMRT treatment plans, to recover significantly improved 3-D measurements of dose. An alternative strategy was also tested, in which the outer surface of the sample was physically removed prior to irradiation. Results show that for the formulation studied here, PRESAGE® samples have a central region that responds uniformly and an edge region of 6–7 mm where there is a gradual increase in dosimeter response, rising to an over-response of 24–36% at the outer boundary. This non-uniform dose-response increases in both extent and magnitude over time. Both mitigation strategies investigated were successful. In our four exemplar studies, we show how discrepancies at edges are reduced from 13–37% of the maximum dose to between 2 and 8%. Quantitative analysis shows that the 3-D gamma passing rates rise from 90.4, 69.3, 63.7 and 43.6% to 97.3, 99.9, 96.7 and 98.9% respectively.
1 May 2017 in Journal of Physics: Conference Series
At the Royal Marsden Hospital (RMH) and the Institute of Cancer Research (ICR) a new MR-linac is being installed and commissioned. Modifications to absorbed dose patterns will occur, because the paths of secondary electrons are deflected by Lorentz forces. In this paper, we describe a methodology to measure the effects of magnetic field on dose distributions, using the PRESAGE® 3D dosimeter and Monte Carlo (MC) simulations. A poly(methyl methacrylate) (PMMA) phantom has been developed to be positioned between the poles of an electromagnet and accommodate cylindrical samples of PRESAGE®. This phantom will be used to study the influence of different magnetic field strengths on radiation deposition from a Cobalt-60 (60Co) beam. Both the orientation of the samples with respect to the magnetic field and radiation beam, and the size of the air gap can be changed. Preliminary MC simulations with two PRESAGE® cylinders separated by an air gap, gave a good insight about the dosimetric effects that can be obtained with our newly-developed phantom.
1 August 2019 in Journal of Physics: Conference Series
With the increasing complexity of radiotherapy treatments typical 1D and 2D quality assurance (QA) detectors may fail to detect out-of-plane dose discrepancies, in particular in the presence of motion. In this work, small samples of the PRESAGE® 3D radiochromic dosimeter were used in combination with a motion phantom to measure real-time multileaf collimator (MLC)-tracked radiotherapy treatments. A different sample of PRESAGE® was irradiated for each of three different irradiation scenarios: (1) static: static sample, without tracking (2) motion: moving sample, without tracking and (3) tracking: moving sample, with tracking. Our in-house software DynaTrack dynamically moves the linac's MLC leafs based on the target position. The doses delivered to the samples were reconstructed based on the recorded positions of the MLC and phantom during the beam delivery. PRESAGE® samples were imaged with an in-house optical-CT scanner. Comparison between simulated and measured 3D dose showed good agreement for all three irradiation scenarios (static: 99.2%; motion: 99.7%; tracking: 99.3% with a 3%, 2 mm and a 10% threshold local gamma criterion), failing only at the edges of the PRESAGE® samples (~ 6 mm). Given that the dose distributions deposited using the DynaTrack system have been independently verified, this experiment demonstrates the ability of PRESAGE to measure 3D doses correctly in a tracking context. We conclude that this methodology could be used in the future to validate the delivery of dynamic MLC-tracked radiotherapy.
1 August 2019 in Journal of Physics: Conference Series
Image Guided Radiotherapy (IGRT) systems allow delivering high doses of radiation to a tumour with great precision and accuracy. In this work, we use patient-specific head MR-based gel dosimeters as an end-to-end test to commission IGRT delivery systems, for stereotactic cranial radiotherapy, and investigate possible sources of errors associated with practical aspects of the measurements. A CT scan of a patient is used to 3D print the shape of the cranial bones to create head phantoms with MR-based gel inside. Each phantom was used as a patient, following the radiotherapy workflow which includes: taking a CT scan of the phantom, calculating the dose distribution using a treatment planning system (TPS) and delivering the radiation calculated by the TPS (to target three different lesions: Big, Medium and Small). Each phantom was then scanned on an MR scanner to obtain a T2 map (linear with dose), which was then rigidly registered with the CT scan of the phantom based on the phantom structures. Good agreement was obtained between the normalized R2 (=1/T2) values and TPS simulations. The relationship between R2 values and dose was investigated based on 3D regions including each lesion. Good linearity was found, but different R2-dose values relationship was obtained depending on the selected regions. The impact of applying a registration based on each lesion (and not the phantom structures) was also tested. Results show that the registration has an impact on the relationship between R2 values and dose, and although absolute dose measurements are still not possible with these MR-based gel dosimeters, they provide very detailed geometrical 3D information to validate IGRT radiotherapy treatments with high level of accuracy.